Weight-associated breast cancer risk is higher in women with cardiovascular disease, IARC analysis shows

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Excess weight is linked to an especially high risk of developing breast cancer in postmenopausal women with cardiovascular disease, according to research from the International Agency for Research on Cancer. The study was published in Cancer.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Substantial differences in the risk of high-grade cervical precancer and cancer were found in an analysis of women’s HPV test results and subsequent clinical assessments conducted by the International Agency for Research on Cancer and partners. Among women who tested positive for HPV, 12% were found to have high-grade cervical precancer or cancer, compared with 0.04% of women who tested negative for HPV.
FDA approved Wilserdly (giredestrant) in combination with everolimus for the treatment of adults with estrogen receptor-positive, human epidermal growth factor receptor 2-negative, ESR1-mutated locally advanced or metastatic breast cancer, as detected by an FDA-authorized test, whose disease has recurred during or after completion of endocrine-based adjuvant therapy, or has progressed on at least one endocrine-based regimen in the metastatic setting.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login